Indaptus Therapeutics (NASDAQ:INDP) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Indaptus Therapeutics (INDP) operate in?

Indaptus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Indaptus Therapeutics Stock (NASDAQ: INDP) stock price, news, charts, stock research, profile.

Open	$0.80
Close	$0.80
Volume / Avg.	37.39K / 25.95K
Day Range	$0.74 - $0.80
52 Wk Range	0.72 - 3.10
Market Cap	$9.61M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	43
Short Interest	0.41%
Days to Cover	2.67

Recent News

Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results.

Avi Kapoor

Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket

Shares of Okta, Inc. (NASDAQ: OKTA) shares rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and

Avi Kapoor

Why Bluegreen Vacations Shares Are Trading Higher By Around 105%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares jumped 396.2% to $145.49 after gaining 100% on Friday. The company’s stock began trading on Friday following merger with Twin Ridge Capital Acquisition Corp.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.80
Close	$0.80
Volume / Avg.	37.39K / 25.95K
Day Range	$0.74 - $0.80
52 Wk Range	0.72 - 3.10
Market Cap	$9.61M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	43
Short Interest	0.41%
Days to Cover	2.67

About Indaptus Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Indaptus Therapeutics (INDP) stock?

You can purchase shares of Indaptus Therapeutics (NASDAQ:INDP) through any online brokerage.

View our list of the best stock brokerages

Who are Indaptus Therapeutics (INDP) competitors?

Other companies in Indaptus Therapeutics’s space includes: Immuron (NASDAQ:IMRN), Can Fite Biofarma (AMEX:CANF), Sensei Biotherapeutics (NASDAQ:SNSE), Portage Biotech (NASDAQ:PRTG) and Ensysce Biosciences (NASDAQ:ENSC).

What is the forecast, or price target, for Indaptus Therapeutics (INDP) stock?

Indaptus Therapeutics has a consensus price target of $8.50.

What is the current price for Indaptus Therapeutics (INDP)?

The stock price for Indaptus Therapeutics (NASDAQ: INDP) is $0.8 last updated February 21, 2025 at 8:17 AM EST.

Does Indaptus Therapeutics (INDP) pay a dividend?

There are no upcoming dividends for Indaptus Therapeutics.

When is Indaptus Therapeutics (NASDAQ:INDP) reporting earnings?

Indaptus Therapeutics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.

Is Indaptus Therapeutics (INDP) going to split?

There is no upcoming split for Indaptus Therapeutics.

What sector and industry does Indaptus Therapeutics (INDP) operate in?

Indaptus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Indaptus Therapeutics

Indaptus Therapeutics (INDP) Forecast